Aardvark Therapeutics, Inc. (AARD)
Aardvark Therapeutics, Inc. (AARD) has reported earnings 7 times since Mar 31, 2025. The stock moves an average of ±6.37% the day after reporting, closing higher 42.9% of the time. Its largest post-earnings gain was +10.39% (Mar 31, 2025) and its largest decline was -8.66% (Nov 13, 2025). The next earnings report is predicted for 2026-11-16 (estimated).
Earnings reactions
How AARD moved on each past earnings report.
Earnings Impact
Total Earnings
7
Avg Abs. Movement
±6.37%
Positive %
42.9%
Negative %
57.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 11, 2026 | ☽ POST | -8.5% | open_in_new |
| May 07, 2026 | ☀ PRE | -5.25% | open_in_new |
| Mar 23, 2026 | ☽ POST | -7.26% | open_in_new |
| Nov 13, 2025 | ☽ POST | -8.66% | open_in_new |
Earnings Count
7
Total earnings in dataset
Avg Abs. Movement
±6.37%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260821 | open_in_new SEC.gov |
| 4 | 20260821 | open_in_new SEC.gov |
| 4 | 20260821 | open_in_new SEC.gov |
| 4 | 20260821 | open_in_new SEC.gov |
| 8-K | 20260817 | open_in_new SEC.gov |
| 10-Q | 20260811 | open_in_new SEC.gov |
| 8-K | 20260811 | open_in_new SEC.gov |
| ARS | 20260710 | open_in_new SEC.gov |
| DEF 14A | 20260710 | open_in_new SEC.gov |
| PRE 14A | 20260629 | open_in_new SEC.gov |
Frequently asked about AARD earnings
When does Aardvark Therapeutics, Inc. report earnings next? expand_more
Aardvark Therapeutics, Inc. (AARD)'s next earnings date is estimated for 2026-11-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does AARD stock move after earnings? expand_more
Over 7 reports, AARD has moved an average of ±6.37% the session after earnings, closing higher 42.9% of the time.
What was AARD's biggest post-earnings move? expand_more
AARD's largest post-earnings gain on record was +10.39% on Mar 31, 2025, and its largest decline was -8.66% on Nov 13, 2025.
Where can I find Aardvark Therapeutics, Inc.'s SEC filings? expand_more
All of Aardvark Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
- Alpha Cognition Inc. Common Stock (ACOG) earnings history chevron_right